Does FGMS flash glucose monitoring system along with self monitoring of blood glucose is a better method compared to self monitoring of blood glucose alone for sugar control

A randomized controlled study Comparing (FGMS) Flash Glucose Monitoring System + SMBG Vs (SMBG) self monitoring of blood glucose alone for glycemic control in adolescents of 12-18years age with Type 1 diabetes mellitus. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008628

Enrollment

Registered

2017-05-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Adolescents with type 1 diabetes mellitus

Interventions

Intervention1: FLASH glucose monitoring system along with self monitoring of blood glucose for sugar monitoring: Intervention group will use FLASH glucose monitoring system in addition to self monitor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adolescents of 12-18years age with type 1 diabetes for at least 1 year who are registered in pediatric endocrinology department 2) Residing in and around Vellore. 3) Patients on basal bolus regimen on insulin with 3-4 injections per day and doing SMBG at least 3-4 times per day for 4days once in every 2 weeks. 4) Hba1c >8% -

Exclusion criteria

Exclusion criteria: 1) Patients age less than 12 and more than 18years. 2) Patients residing far from Vellore. 3) Patients with HbA1c 14%. 4) Patients with other endocrinal co- morbidities. 5) Patients on corticosteroid therapy or any other major systemic illness.

Design outcomes

Primary

Measure	Time frame
1) Glycemic control as assessed by reduction in HbA1c 2) Identification of hyper and hypo glycemic episodes 3) To assess efficacy of FGMS in reducing total insulin requirement 4) Feasibility and acceptability of FGMS Timepoint: February till march 2017	—

Secondary

Measure	Time frame
1) To assess efficacy of FGMS in reducing total insulin requirement 2) Feasibility and acceptability of FGMS Timepoint: February till march 2017	—

Countries

India

Contacts

Public ContactSophy Korula

Christian medical college ,vellore

annasimon@cmcvellore.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026